Prova Get the app

Guides

Zepbound injection sites

The three Zepbound injection sites in the label, whether the site changes how well it works, how to rotate, and what the label says about site reactions.

October 29, 20263 min read2 sources

Facts on this page come from FDA labels and official sources, listed at the end. It's general information, not medical advice: your prescriber comes first.

Zepbound goes under the skin in one of three places: the stomach (abdomen), the thigh, or the back of the upper arm, and the label says the upper arm is for someone else to inject. It also says you get similar exposure to the drug from all three, so the label doesn't name a best site.

Where can you inject Zepbound?

The Medication Guide puts it in one line: "Inject ZEPBOUND under the skin (subcutaneously) of your stomach (abdomen), thigh, or another person should inject in the back of the upper arm."

SiteWho can inject thereWhat the label adds
Stomach (abdomen)You or another person"at least 2 inches from the belly button"
ThighYou or another personNothing more
Back of the upper armAnother person"Another person should give you the injection in the back of your upper arm."

Does the injection site make a difference?

For how much drug reaches your blood, the label says no. The pharmacology section reads: "Similar exposure was achieved with subcutaneous administration of tirzepatide in the abdomen, thigh, or upper arm." It puts average absorption from under the skin at 80%, with the peak level about 24 hours after the shot (anywhere from 8 to 72 hours).

People also ask whether one site means less nausea. The label doesn't compare side effects by site at all. If you notice a pattern, like more nausea in the week after a belly shot, write the site and the effect down for a few weeks and show your prescriber.

How to rotate Zepbound injection sites

The prescribing information says: "Rotate injection sites with each dose." The patient instructions are more precise. You may stay in the same area, "but be sure to choose a different injection site in that area. Do not use the same site for each injection."

The reason is in the label too: "Change (rotate) your injection site within the area you choose for each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites."

Some people go left belly, right belly, left thigh, right thigh, then start over. Whatever order you use, you need to know where last week's shot went, and the printable shot log has a site column for that.

Where not to inject

  • "Do not inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin."
  • "Do not inject ZEPBOUND in the same injection site used for other medicines."

On the belly, the 2-inch rule around the belly button applies too. The second line covers any other shot you give yourself, insulin included.

Injection site reactions: redness, itching, bruising

Injection site reactions are on the label's list of common side effects. In the two main weight loss trials they were reported by 6% of people on 5 mg, 8% on 10 mg and 8% on 15 mg, against 2% on placebo. That count covers several terms: "injection site bruising, injection site erythema, injection site pruritus, injection site pain, injection site rash, injection site reaction." Erythema is redness, pruritus is itching.

Site reactions were more frequent in people who developed antibodies to tirzepatide (11.3%) than in those who didn't (1%). The label doesn't give a treatment for site reactions, and it doesn't say how long they last. A red or itchy spot that keeps coming back, or one that gets worse, is a question for your prescriber or pharmacist.

When a reaction is more than the site

The Medication Guide says: "Stop using ZEPBOUND and get medical help right away if you have any symptoms of a serious allergic reaction including:"

  • swelling of your face, lips, tongue or throat
  • problems breathing or swallowing
  • severe rash or itching
  • fainting or feeling dizzy
  • very rapid heartbeat

Getting ready: the pen, the vial, the liquid

The instructions don't make you warm the pen: "It is not necessary to warm the pen to room temperature." With a vial, you wipe the rubber stopper with an alcohol swab, and the label asks for "a new syringe and needle for each injection." Look at the liquid first. It should be "clear and colorless to slightly yellow," and not used if you see particles or discoloration.

For time of day and a late or early shot, see Zepbound shot day tips. The Zepbound dosage chart covers the doses and the volume of each pen and vial.

Sources

  1. Zepbound (tirzepatide) prescribing information, Eli Lilly, revised 08/2026Checked October 29, 2026
  2. Zepbound label, Medication Guide and Instructions for Use, DailyMed (National Library of Medicine)Checked October 29, 2026